Digital Pathology Market Size is Projected To Reach USD 1742.7 Million By 2028 At A CAGR Of 13.1% | Valuates Reports

BANGALORE, India, June 3, 2022 /PRNewswire/ -- Digital Pathology Market is Segmented by Type  - Whole Slide Imaging, Image Analysis-Informatics, Information Management System Storage & Communication, Digital IVD Devices, Others , by Application  -  Pharma & Biotech Companies, Hospital & Diagnostic Centers, Educational Institutes. Global Opportunity Analysis and Industry Forecast 2022 - 2028. It is published in Valuates Reports under the Nursing Category.

Digital Pathology Market size is projected to reach USD 1742.7 million by 2028, from USD 729 million in 2021, at a CAGR of 13.1% during 2022-2028.

Major factors driving the growth of Digital Pathology Market are

The increasing usage of digital pathology to improve lab efficiency, the rising incidence of chronic disease, and the growing applications of digital pathology in drug discovery and companion diagnostics are all driving the growth of the digital pathology market.

The digital pathology market is rapidly gaining momentum as a proven and essential technology; with specific support for education, tissue-based research, drug development, and the practice of human pathology throughout the world. It is an innovation committed to the reduction of laboratory expenses, an improvement of operational efficiency, enhanced productivity, and improving treatment decisions and patient care.

Browse The Table Of Contents And List Of Figures At:  https://reports.valuates.com/market-reports/QYRE-Auto-9Z659/global-digital-pathology

TRENDS INFLUENCING THE GROWTH OF DIGITAL PATHOLOGY  MARKET

The increasing need to enhance lab efficiency is expected to drive the growth of the digital pathology market. Digital pathology is a cutting-edge technology that aims to lower laboratory costs, increase operational efficiency, boost production, and improve treatment decisions and patient care. Improved analysis, reduced errors, better visualization, improved workflow, reduced turnaround time, cost-effectiveness, and breaking geographical barriers are just a few of the advantages of digital pathology.

Clinical labs use digital pathology for remote consultations, education, and quantitative analysis on a limited number of cases. To help assign cases to pathologists, manage workflow into worklists, offer quantitative image analysis for specific case types, integrate information into their existing Lab Information System (LIS), and expand access to cases beyond the brick-and-mortar walls of the lab, these labs use computationally enabled digital pathology powered by AI.

Growing adoption of IVD is expected to further boost the digital pathology market growth. Digital Pathology Devices like In vitro diagnostic (IVD) devices, including genetic tests, provide information that is used to inform health care decision-making. Commercial test items and testing instruments, among other things, are examples of IVDs used in laboratory analysis of human samples.

Furthermore, increasing chronic diseases is expected to further propel the Digital Pathology market. In many circumstances, early identification of infections might mean the difference between life and death. Pathology slides are tissue sections that have been specifically dyed so that a pathologist may examine them and determine whether they contain indications of cancer or other chronic disorders.

Pathologists and clinicians use these images to diagnose cancer, determine the severity of the disease, and determine the best course of treatment for patients. Artificial intelligence (AI) can also be used in digital pathology to speed up or improve diagnosis. In the future, computer programs may aid in the detection of small areas of cancer that have spread to lymph nodes, the better quantification and measurement of tumors, and the speedy direction of pathologists to areas of abnormalities in the tissue.

Increasing demand for digital pathology in the drug development process is expected to further drive market growth. By allowing data sharing between distant pharma pathology labs around the world, digital pathology is changing global pharmaceutical research. With such huge financial stakes, the biotech and pharmaceutical industries are rapidly looking for novel ways to improve performance while retaining quality and consistency.

They would be able to construct a multi-site, digitized environment with digital pathology, allowing for instant web-based consultations between, say, preclinical biomarker teams or clinical researchers. Experts would be able to cooperate and assess tissue-based toxicity and efficacy studies with significantly higher speed, precision, and accuracy in this fashion.

Moreover, clinical pathology research and everyday practices rely heavily on digital pathology. It focuses on organizing information obtained from digitized slides, allowing digital picture sharing across sites for education, research, and diagnosis, and assisting in detailed and quantitative tissue analysis using features such as seeing from different angles or zooming in and out.

Get Your Sample Today:  https://reports.valuates.com/request/sample/QYRE-Auto-9Z659/Global_Digital_Pathology_Market

DIGITAL PATHOLOGY MARKET SHARE ANALYSIS

Based on type, Digital IVD Devices is the most lucrative segment, with a share of over 35%. This is because, at hospitals and diagnostic institutes, IVD is utilized to provide reliable lab results and detect chronic diseases early.

Based on application, the largest segment is Hospital & Diagnostic Centers, followed by Pharma & Biotech Companies. This is due to the increase in the number of chronic diseases, and cardiac disorders, and the demand for digital pathology systems for disease diagnostics. However, due to an increase in the number of cancer patients, increased usage of digital pathology systems, and the development of new digital pathology systems in clinical laboratories, drug discovery is likely to grow significantly during the forecast period.

Based on region,  North America held the largest market share of over 40%, followed by Europe and China, both held a share of over 35 percent. The rise in the number of different types of cancer cases, the presence of major actors, the development of the healthcare sector, and the presence of new innovative digital pathology systems in the region are all contributing to North America's growth.

Inquire For Customization: 

https://reports.valuates.com/request/customisation/QYRE-Auto-9Z659/Global_Digital_Pathology_Market

Market By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Inquire for Regional Report:

https://reports.valuates.com/request/regional/QYRE-Auto-9Z659/Global_Digital_Pathology_Market

Key Companies:

• Danaher
• Hamamatsu Photonics
• Roche
• Philips
• Olympus
• PerkinElmer
• Sectra
• Nikon
• Definiens
• 3DHISTECH
• Visiopharm
• Apollo Enterprise Imaging
• Glencoe Software
• Indica Labs
• OptraSCAN
• Objective Pathology
• Digipath
• Pathcore

Inquire for Chapter Cost:

https://reports.valuates.com/request/chaptercost/QYRE-Auto-9Z659/Global_Digital_Pathology_Market

Buy Now for Single User + Covid-19 Impact :

https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-9Z659&lic=single-user

SIMILAR REPORTS:

-  The global Next Generation Sequencing Market size was valued at USD4,533 million in 2018, and is estimated to reach USD18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.

-  The global Digital Healthcare market size is projected to reach USD 95430 Million by 2026, from USD 77240 Million in 2020, at a CAGR of 22.4% during 2021-2026.

-  The Biosimilar market was valued at USD 9752.7 million in 2022, and it is anticipated to reach USD 22550 million by 2028, registering a CAGR of about 15.0% during the forecast period 2022–2028.

-  The global healthcare analytics market size was valued at USD 23.51 billion in 2020 and is projected to reach USD 96.90 billion by 2030, growing at a CAGR of 15.3% from 2021 to 2030.

-  The global Sterilization Equipment market was valued at USD 1674.3 million in 2022 and is expected to reach USD 2005.8 million by the end of 2028, growing at a CAGR of 3.06% from 2022 to 2028.

-  The global Allergy Diagnostics market size is projected to reach USD 5510 million by 2028, from USD 3563.9 million in 2021, at a CAGR of 6.0% during 2022-2028.

-  The global Neurostimulation Devices market size is estimated to be worth USD 7454.1 million in 2022 and is forecast to a readjusted size of USD 14170 million by 2028 with a CAGR of 11.3% during the review period.

-  The global Medical Tubing market size is estimated to be worth USD 8136.6 million in 2022 and is forecast to be a readjusted size of USD 13570 million by 2028 with a CAGR of 8.9% during the review period.

-  The global Blood Collection market size is projected to reach USD 7164.1 Million by 2027, from USD 4440.6 Million in 2020, at a CAGR of 7.1% during 2021-2027.

-  The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.

-  The global Laboratory Proficiency Testing market size is projected to reach USD 899.6 million by 2028, from USD 675 million in 2021, at a CAGR of 3.7% during 2022-2028.

-  The global Lab Automation market size is estimated to be worth USD 13760 Million in 2022 and is forecast to a readjusted size of USD 19820 Million by 2028 with a CAGR of 6.3% during the forecast period 2022-2028.

-  The global Laboratory Information Management System (LIMS) market size is projected to reach USD 1503.3 Million by 2028, from USD 889 Million in 2021, at a CAGR of 7.7% during 2022-2028.

-  The global digital polymerase chain reaction market generated D508.8 million in 2020 and is projected to reach D1,139.9 million by 2028, growing at a CAGR of 9.1% from 2021 to 2028.

-  The global Medical Oxygen Concentrators market size is estimated to be worth USD 2861.4 million in 2022 and is forecast to a readjusted size of USD 3222.4 million by 2028 with a CAGR of 2.0% during the review period.

-  Global Women Healthcare Market Insights and Forecast to 2028

Click here to see related reports on Digital Pathology Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:

Valuates Reports
sales@valuates.com 
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg